SG
BSX icon

StoneX Group’s Boston Scientific BSX Stock Holding History

StoneX Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
7,137
+107
+2% +$5.81K 0.01% 811
2026
Q1 		$441K Buy
7,030
+2,135
+44% +$171K 0.02% 458
2025
Q4 		$467K Sell
4,895
-337
-6% -$33K 0.02% 554
2025
Q3 		$511K Sell
5,232
-680
-12% -$70.4K 0.02% 524
2025
Q2 		$635K Buy
5,912
+322
+6% +$32.6K 0.03% 438
2025
Q1 		$564K Sell
5,590
-252
-4% -$25.4K 0.03% 442
2024
Q4 		$522K Buy
+5,842
New +$514K 0.03% 458

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

StoneX Group's BSX Position: Q2 2026 in Review

StoneX Group increased its Boston Scientific (BSX) stake by 1.5% in Q2 2026, buying an estimated $5.81K and bringing the position to 7,137 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #811.

StoneX Group first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $635K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • StoneX Group held 7,137 shares of Boston Scientific worth $305K as of Q2 2026.
  • StoneX Group bought 107 Boston Scientific shares in Q2 2026, an estimated $5.81K.
  • Boston Scientific made up 0.01% of StoneX Group's portfolio in Q2 2026, its #811 holding.
  • StoneX Group first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • StoneX Group's Boston Scientific position peaked at $635K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.